Skip to main content
SpringerLink
Log in

Sleep and Quality of Life in Parkinson’s Disease

  • Chapter
Sleep and Quality of Life in Clinical Medicine

Summary

Sleep disturbances in Parkinson’s disease (PD) are both widespread and wide-ranging. Emerging early in the disease process, sometimes prior to the onset of motor symptoms, sleep disruption results from the degeneration of the basal ganglia that is the hallmark of the disease, as well as changes in brain stem sleep centres. Accordingly, sleep problems consist of motor symptoms such as stiffness, difficulty turning and dystonia as well as disruption to the normal sleep–wake cycle, arousal and alertness. Sleep disruption has been associated with reduced quality of life (QOL) and increased depression and anxiety in PD patients and their caregivers alike, and may be severe enough to impair everyday functioning. It is also likely that presence of certain sleep symptoms such as REM behaviour disorder (RBD) and sleep-disordered breathing (SDB) are the harbingers of a poor prognosis. Although no studies have yet investigated the effect of sleep problems on institutionalization in PD, chronic disruption to the sleep of caregivers may well lead to a breakdown in the caregiving relationship and care arrangements. The following article reviews the prevalence, phenomenology, pathophysiology and impact of sleep disturbances on QOL for individuals with PD and their caregivers. Clinical management strategies are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 2006;5:235–45.

    Article  PubMed  Google Scholar 

  2. Pal PK, Calne S, Samii A, Fleming JAE. A review of normal sleep and its disturbances in Parkinson’s disease. Parkinsonism Relat Disord 1999;5:1–17.

    Article  PubMed  CAS  Google Scholar 

  3. Chaudhuri KR, Martinez-Martin P, Schapira AHV, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: The NMSQuest study. Mov Disord 2006;21: 916–23.

    Article  PubMed  Google Scholar 

  4. Garcia-Borreguero D, Larrosa O, Bravo M. Parkinson’s disease and sleep. Sleep Med Rev 2003;7:115–29.

    Article  PubMed  Google Scholar 

  5. Dhawan V, Healy DG, Pal S, Chaudhuri KR. Sleep-related problems of Parkinson’s disease. Age Ageing 2006;35:220–8.

    Article  PubMed  CAS  Google Scholar 

  6. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 1998;13:895–9.

    Article  PubMed  CAS  Google Scholar 

  7. Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, Hogl B, Trenkwalder C. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatr 2002;73:629–35.

    Article  PubMed  CAS  Google Scholar 

  8. Chaudhuri KR, Schapira AHV, Martinez-Martin P, et al. The holistic management of Parkinson’s using a novel non motor symptom scale and questionnaire. Adv Clinc Neurosci Rehab 2004;4:20–4.

    Google Scholar 

  9. Lees A, Blackburn N, Cambell V. The nighttime problems of Parkinson’s disease. Clin Neuropharmacol 1988;11:512–9.

    Article  PubMed  CAS  Google Scholar 

  10. Stocchi F, Brusa L, Vacca L, De Pandis MF, Grassini P, Berardelli A, Ruggieri S. Sleep disturbances in Parkinson’s disease. Eur J Neurol 2000;7:21–5.

    Google Scholar 

  11. Chaudhuri KR, Martinez-Martin P. Clinical assessment of nocturnal disability in Parkinson’s disease – The Parkinson’s disease sleep scale. Neurology 2004;63:S17–20.

    PubMed  Google Scholar 

  12. Happe S, Kungel M, Rink P, Ebrecht M, Modell S, Trenkwalder C. Effects of controlled-release L-DOPA (NACOM ® Retard/Sinemet ™s CR) on sleep, motor fluctuations and quality of life in patients with Parkinson’s disease. Mov Disord 2004;19:S273–4.

    Article  Google Scholar 

  13. Ghatani T, Agapito C, Bhattacharya KF, Clough C, Chaudhuri KR. Comparative audit of pergolide and cabergoline therapy in the treatment of nocturnal ‘off’ periods causing sleep disruption in Parkinson’s disease. Eur J Neurol 2001;8:8–11.

    Google Scholar 

  14. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study. Mov Disord 1999;14:922–7.

    Article  PubMed  CAS  Google Scholar 

  15. Merello M, Hughes A, Colosimo C, Hoffman M, Starkstein S, Leiguarda R. Sleep benefit in Parkinson’s disease. Mov Disord 1997;12:506–8.

    Article  PubMed  CAS  Google Scholar 

  16. Atassi F, Vuong KD, Jankovic J, Ondo WG. The prevalence of restless legs syndrome in patients with Parkinson’s disease. Neurology 2001;56:A21.

    Google Scholar 

  17. Dhawan V, Chaudhuri K R. Restless legs syndrome and Parkinson’s disease. In Restless Legs Syndrome. Edited by WG Ondo. Informa Healthcare USA Inc: NY, 2007, pp. 247–54.

    Google Scholar 

  18. Tan EK, Lum SY, Wong MC. Restless legs syndrome in Parkinson’s disease. J Neurol Sci 2002;196:33–6.

    Article  PubMed  CAS  Google Scholar 

  19. Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005;28:499–521.

    PubMed  Google Scholar 

  20. Oerlemans WGH, de Weerd AW. The prevalence of sleep disorders in patients with parkinson’s disease. A self-reported, community-based survey. Sleep Med 2002;3:147–9.

    Article  PubMed  Google Scholar 

  21. Andersen JT. Disturbances of bladder and urethral function in Parkinson’s disease. Int Urol Nephrol 1985;17:35–41.

    Article  PubMed  CAS  Google Scholar 

  22. Trenkwalder C. Sleep dysfunction in Parkinson’s disease. Clin Neurosci 1998;5:107–14.

    PubMed  CAS  Google Scholar 

  23. Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinsons-disease patients with treatment-induced hallucinations. Ann Neurol 1993;34:710–4.

    Article  PubMed  CAS  Google Scholar 

  24. Diederich NJ, Vaillant M, Mancuso G, Lyen P, Tiete J. Progressive sleep ‘destructuring’ in Parkinson’s disease. A polysomnographic study in 46 patients. Sleep Med 2005;6:313–8.

    Article  PubMed  Google Scholar 

  25. Happe S, Klosch G, Lorenzo J, et al. Perception of sleep: Subjective versus objective sleep parameters in patients with Parkinson’s disease in comparison with healthy elderly controls. J Neurol 2005;252:936–43.

    Article  PubMed  Google Scholar 

  26. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson’s disease. Mov Disord 1990;5:280–5.

    Article  PubMed  CAS  Google Scholar 

  27. Menza MA, Rosen RC. Sleep in Parkinson’s disease: the role of depression and Anxiety. Psychosomatics 1995;36:262–6.

    PubMed  CAS  Google Scholar 

  28. Saper CB, Cano G, Scammell TE. Homeostatic, circadian, and emotional regulation of sleep. J Comp Neurol 2005;493:92–8.

    Article  PubMed  CAS  Google Scholar 

  29. Gjerstad MD, Aarsland D, Larsen JP. Development of daytime somnolence over time in Parkinson’s disease. Neurology 2002; 58:1544–6.

    PubMed  CAS  Google Scholar 

  30. Rye DB, Bliwise DL, Dihenia B, Gurecki P. Daytime sleepiness in Parkinson’s disease. J Sleep Res 2000;9:63–9.

    Article  PubMed  CAS  Google Scholar 

  31. Ghorayeb I, Loundou A, Auquier P, Bioulac B, Tison F. A nationwide survey of excessive daytime sleepiness in ambulatory patients with Parkinson’s disease in France. Mov Disord 2006;21:S542.

    Google Scholar 

  32. Whitney CW, Enright PL, Newman AB, Bonekat W, Foley D, Quan SF. Correlates of daytime sleepiness in 4578 elderly persons: the cardiovascular health study. Sleep 1998;21: 27–36.

    PubMed  CAS  Google Scholar 

  33. Ghorayeb I, Yekhlef F, Chrysostome V, Balestre E, Bioulac B, Tison F. Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatr 2002;72:798–800.

    Article  PubMed  CAS  Google Scholar 

  34. Meindorfner C, Korner Y, Moller JC, Stiasny-Kolster K, Oertel GH, Kruger HP. Driving in Parkinson’s disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 2005;20:832–42.

    Article  PubMed  Google Scholar 

  35. Tan EK, Lum SY, Fook-Chong SMC, Teoh ML, Yih Y, Tan L, Tan A, Wong MC. Evaluation of somnolence in Parkinson’s disease: comparison with age and sex-matched controls. Neurology 2002;58:465–8.

    PubMed  CAS  Google Scholar 

  36. Merino-Andreu M, Arnulf I, Konofal E, Derenne JP, Agid Y. Unawareness of naps in Parkinson’s disease and in disorders with excessive daytime sleepiness. Neurology 2003;60:1553–4.

    PubMed  CAS  Google Scholar 

  37. Schenck C, Bundlie S, Ettinger M, Mahowald M. Chronic behavioural disorders of human REM sleep: a category of parasomnia. Sleep 1986;9:293–308.

    PubMed  CAS  Google Scholar 

  38. Boeve B, Silber MH, Parisi JE, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003;61:40–5.

    PubMed  CAS  Google Scholar 

  39. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996;46:388–93.

    PubMed  CAS  Google Scholar 

  40. Gagnon JF, Bedard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology 2002;59:585–9.

    PubMed  CAS  Google Scholar 

  41. Comella CL, Nardine TM, Diederich NJ, Stebbins GT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease. Neurology 1998;51:526–9.

    PubMed  CAS  Google Scholar 

  42. Scaglione C, Vignatelli L, Plazzi G, et al. REM sleep behaviour disorder in Parkinson’s disease: a questionnaire-based study. Neurol Sci 2005;25:316–21.

    Article  PubMed  CAS  Google Scholar 

  43. De Cock VC, Vidailhet M, Leu S, et al. Restoration of normal motor control in Parkinson’s disease during REM sleep. Brain 2007;130:450–6.

    Article  PubMed  Google Scholar 

  44. Diederich NJ, Vaillant M, Leischen M, Mancuso G, Golinval S, Nati R, Schlesser M. Sleep apnea syndrome in Parkinson’s disease. A case-control study in 49 patients. Mov Disord 2005;20:1413–8.

    Article  PubMed  Google Scholar 

  45. Braga-Neto P, da Silva FP, Monte FS, de Bruin PFC, de Bruin VMS. Snoring and excessive daytime sleepiness in Parkinson’s disease. J Neurol Sci 2004;217:41–5.

    Article  PubMed  Google Scholar 

  46. Sharf B, Moskovitz C, Lupton MD, Klawans HL. Dream phenomena induced by chronic levodopa therapy. J Neural Transm 1978;43:143–51.

    Article  PubMed  CAS  Google Scholar 

  47. Moskovitz C, Moses H, III, Klawans HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry 1978;135:669–75.

    PubMed  CAS  Google Scholar 

  48. Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain 2000;123(Pt 4):733–45.

    Article  PubMed  Google Scholar 

  49. Manni R, Pacchetti C, Terzaghi M, Sartori I, Zangaglia R, Nappi G. Sleep-wake cycle and visual hallucinations in Parkinson’s disease. Mov Disord 2002;17:368.

    Article  Google Scholar 

  50. Arnulf I, Bonnet AM, Damier P, Bejjani BP, Seilhean D, Derenne JP, Agid Y. Hallucinations, REM sleep, and Parkinson’s disease: a medical hypothesis. Neurology 2000;55:281–8.

    PubMed  CAS  Google Scholar 

  51. Boeve BF, Silber MH, Ferman TJ. REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004;17:146–57.

    Article  PubMed  Google Scholar 

  52. Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001;16:622–30.

    Article  PubMed  CAS  Google Scholar 

  53. Eisensehr I, von Lindeiner H, Jager M, Noachtar S. REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson’s disease: is there a need for polysomnography? J Neurol Sci 2001;186:7–11.

    Article  PubMed  CAS  Google Scholar 

  54. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder – comparison with Parkinson’s disease and controls. Brain 2000;123: 1155–60.

    Article  PubMed  Google Scholar 

  55. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 2002;58:341–6.

    PubMed  Google Scholar 

  56. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 2004;318:121–34.

    Article  PubMed  Google Scholar 

  57. Abbott RD, Ross GW, White LR, Tanner CM, Nelson JS, Petrovitch H. Excessive daytime sleepiness and the future risk of Parkinson’s disease. Mov Disord 2005;20:S101.

    Google Scholar 

  58. Fronczek R, Overeem S, Lee S, et al. Hypocretin (orexin) loss in Parkinson’s disease. Brain 2007;130:1586–95.

    Article  Google Scholar 

  59. Druout X, Moutereau S, Nguyen JP, et al. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 2003;61:540–3.

    Google Scholar 

  60. Baumann C, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti CL. Parkinsonism with excessive daytime sleepiness-A narcolepsy-like disorder? J Neurol 2005;252:139–45.

    Article  PubMed  Google Scholar 

  61. Arnulf I. Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 2005;9:185–200.

    Article  PubMed  Google Scholar 

  62. Jenkinson C, Peto V, Fitzpatrick R, et al. Self-reported functioning and well-being in patients with Parkinson’s disease: comparison of the Short-form Health Survey (SF-36) and the Parkinson’s Disease Questionnaire (PDQ-39). Age Ageing 1995;24:505–9.

    Article  PubMed  CAS  Google Scholar 

  63. Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N. The parkinson’s disease questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing 1997;26:353–7.

    Article  PubMed  CAS  Google Scholar 

  64. Morrish P. Quality of Life in Parkinsons Disease. Parkinsons Disease 2002;4(1):1–3.

    Google Scholar 

  65. Karlsen K H, Larsen J P, Tandberg E, et al. Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1999; 66:431–5.

    PubMed  CAS  Google Scholar 

  66. Boczarska-Jedynak M, Opala G. Sleep disturbances in Parkinson’s disease. Neurologia i Neurochirugia Polska 2005; 39(5):380–88.

    Google Scholar 

  67. Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F. Health related quality of life and sleep disorders in Parkinson’s disease. Neurological Sci 2003;24(3):209–10.

    Article  CAS  Google Scholar 

  68. Weintraub D, Moberg PJ, Duda JE, et al. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson’s disease. J Am Geriatr Soc 2004;52(5):784–8.

    Article  PubMed  Google Scholar 

  69. Comella C. Sleep disturbances and excessive daytime sleepiness in Parkinson’s disease: an overview. J Neural Trans 2006;70:349–55.

    Article  Google Scholar 

  70. Korczyn AD. Autonomic nervous system disturbances in Parkinson’s disease. In: Advances in Neurology: Parkinson’s Disease: Anatomy, Pathology and Therapy, vol. 53. Edited by Streifler MB, Korczyn AD, Melamed E, Youdim MB. Raven Press: New York, 1990: pp. 463–8.

    Google Scholar 

  71. Sanford IR. Tolerance of debility in elderly dependents by supports at home: its significance for hospital practice. Br Med J 1975;3:471–3.

    PubMed  CAS  Google Scholar 

  72. Pollack CP, Perlick D. Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol 1991;4:204–10.

    Article  Google Scholar 

  73. Happe S, Berger K. The association between caregiver burden and sleep disturbances in partners of patients with Parkinson’s disease. Age Ageing 2002;31(5):349–54.

    Article  PubMed  Google Scholar 

  74. Crabb L. Sleep disorders in Parkinson’s disease: the nursing role. Br J Nurs 2001;10(1):42–7.

    PubMed  CAS  Google Scholar 

  75. Boeve BF, Silber MH, Ferman TJ. REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004;17(3):146–57.

    Article  PubMed  Google Scholar 

  76. Chaudhuri KR, Ellis C, Love-Jones S, Thomaides T,Clift S, Mathias CJ, Parkes JD. Postprandial hypotension and parkinsonian state in Parkinson’s disease. Mov Disord 1997;12(6):877–84.

    Article  PubMed  CAS  Google Scholar 

  77. Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213.

    Article  PubMed  CAS  Google Scholar 

  78. Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM. Development of a questionnaire for sleep and sleepiness in Parkinson’s disease. Sleep 2003;26:1049–1054.

    PubMed  Google Scholar 

  79. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540–5.

    PubMed  CAS  Google Scholar 

  80. Marinus J, Visser M, Partinez-Martin P, et al. A short psychosocial questionnaire for patients with Parkinson’s Disease: the SCOPA-PS. J Clin Epidemiol 2003:56: 61–7.

    Article  PubMed  Google Scholar 

  81. De Boer AG, Wijker W, Speelman JD, De Haes JC. Quality of life in patients with Parkinson’s disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 2002;158:41–50.

    Google Scholar 

  82. Marinus J, Visser M, van Hilten JJ, et al. Assessment of sleep and sleepiness in Parkinson disease. Sleep 2003;26:1049–54.

    PubMed  Google Scholar 

  83. Schrag A, Selai C, Jahanshahi M, Quinn NP. The EQ-5D–a generic quality of life measure is an useful instrument to measure quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 2000;69:67–73.

    Article  PubMed  CAS  Google Scholar 

  84. Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J; Parkinson Study Group. Development and testing of the Parkinson’s disease quality of life scale. Mov Disord 2003;18:637–45.

    Article  PubMed  Google Scholar 

  85. Grosset D, Taurah L, Burn DJ, et al. A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson’s disease left untreated at diagnosis. J Neurol Neurosurg Psychiatry 2007;78:465–9.

    Article  PubMed  CAS  Google Scholar 

  86. Martinez-Martin P, O’Brien C. Extending levodopa action: COMT inhibition. Neurology 1998;50:527–32.

    Google Scholar 

  87. Block G, Liss C, Reines S, et al. Comparison of immediate release and controlled release carbidopa/Levodopa in Parkinson’s disease. A multicentre 5 year study.Eur Neurol 1997;37:23–7.

    Google Scholar 

  88. Parkinson Study Group. Pramipexole versus levodopa as initial treatment for Parkinson’s disease. A 4 year randomised controlled trial. Arch Neurol 2004;61:1044–53.

    Article  Google Scholar 

  89. Biglan KM, Schwid S, Eberly S, et al. Rasagiline improves quality of life in patients with early Parkinson’s disease. Mov Disord 2006;21(5):616–23.

    Article  PubMed  Google Scholar 

  90. Giladi N, Boroojerdi B. Rotigotine transdermal patch for 24 h can improve sleep quality in patients with Parkinson’s disease: report from two open label trials. Eur J Neurol 2006;13(suppl 2):321.

    Google Scholar 

  91. Hogl B, Saletu B, Brandauer E, et al. Modafinil for the treatment of daytime sleepiness in Parkinson’s disease: a double blind, randomised, crossover, placebo controlled, polygraphic trial. Sleep 2002;25(8):905–9.

    PubMed  CAS  Google Scholar 

  92. Grosset D. The rotigotine transdermal patch may provide continuous dopaminergic stimulation in early-stage Parkinson’s disease. Adv Clin Neurol Rehab 2006; 6(2):32–4.

    Google Scholar 

  93. Hjort N, Ostergaard K, Dupont E. Improvement of sleep quality in patients with advanced Parkinson’s disease treated with deep brain stimulation of the subthalamic nucleus. Mov Disord 2004;19:196–9.

    Article  PubMed  Google Scholar 

  94. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. NEJM 2006;355:896–908.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Daisy L. Whitehead
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosalind Mitchell-Hay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prashant Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sharon Muzerengi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Ray Chaudhuri
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Section Psychopharmacology Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3508TB, PoBox 80082, Utrecht, The Netherlands

    Joris C. Verster

  2. Divison of Clinical Pharmacology and Experimental Therapeutics Department of Medicine, College of Physicians and Surgeons of Columbia University, 630 West 168th Street - Rm # BB813, New York, NY 10032, USA

    S. R. Pandi-Perumal

  3. Department of Psychiatry, Kunin-Lunenfeld Applied Research Unit (KLARU), 3560 Bathurst St., Toronto, M6A 2E1, Canada

    David L. Streiner

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, Totowa, NJ

About this chapter

Cite this chapter

Whitehead, D.L., Mitchell-Hay, R., Reddy, P., Muzerengi, S., Chaudhuri, K.R. (2008). Sleep and Quality of Life in Parkinson’s Disease. In: Verster, J.C., Pandi-Perumal, S.R., Streiner, D.L. (eds) Sleep and Quality of Life in Clinical Medicine. Humana Press. https://doi.org/10.1007/978-1-60327-343-5_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-343-5_20

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-340-4

  • Online ISBN: 978-1-60327-343-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation